Home › Funds › Groupe Bruxelles Lambert › CNXC
Groupe Bruxelles Lambert position in CNXC
CONCENTRIX CORP · Technology
Groupe Bruxelles Lambert reported holding 657,194 shares of CNXC (CONCENTRIX CORP) in its Q3 2026 13F filing — a position valued at US$16.4M, representing 100.00% of its reported portfolio and ranking #1 among its reported holdings. Groupe Bruxelles Lambert has disclosed CNXC holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Groupe Bruxelles Lambert's CNXC position evolved
Groupe Bruxelles Lambert first disclosed a stake in CNXC in Q4 2023 at 8,773,667 shares (US$861.7M). Across 12 filings, Groupe Bruxelles Lambert increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 657,194 shares valued at US$16.4M — a reduction of -2,116,473 shares quarter over quarter.. Notable position changes include a 68% trim in Q2 2026 (shares rose 11% over the following quarter), a 76% trim in Q3 2026 (shares rose 31% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 8.77M | $861.66M | New |
| Q1 2024 | 8.77M | $580.99M | Hold |
| Q2 2024 | 8.77M | $555.20M | Hold |
| Q3 2024 | 8.77M | $449.65M | Hold |
| Q4 2024 | 8.77M | $379.64M | Hold |
| Q1 2025 | 8.77M | $488.17M | Hold |
| Q2 2025 | 8.77M | $463.73M | Hold |
| Q3 2025 | 8.77M | $404.90M | Hold |
| Q4 2025 | 8.77M | $364.81M | Hold |
| Q1 2026 | 8.77M | $240.05M | Hold |
| Q2 2026 | 2.77M | $62.16M | Reduce |
| Q3 2026 | 657.19K | $16.40M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CNXC and 13F data
CNXC (CONCENTRIX CORP) is a Technology company. 18 other funds we track also report a position in CNXC — the largest reported positions include Kopernik Global Investors, LLC (US$71.2M), LYRICAL ASSET MANAGEMENT LP (US$32.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CNXC
- Kopernik Global Investors, LLC 3.18M sh · $71.15M · Q2 2026
- LYRICAL ASSET MANAGEMENT LP 1.29M sh · $32.28M · Q3 2026
More on Groupe Bruxelles Lambert
FAQ
How long has Groupe Bruxelles Lambert held CNXC?
Groupe Bruxelles Lambert has disclosed CNXC holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Groupe Bruxelles Lambert's current position in CNXC?
As of Q3 2026, Groupe Bruxelles Lambert holds 657.19K shares of CNXC (CONCENTRIX CORP), valued at $16.40M, representing 100.00% of its reported portfolio and ranking #1.
Has Groupe Bruxelles Lambert been buying or selling CNXC?
In the latest 13F filing (Q3 2026), Groupe Bruxelles Lambert reduced its position in CNXC.
Which other funds hold CNXC?
Other major institutional holders of CNXC include Kopernik Global Investors, LLC, LYRICAL ASSET MANAGEMENT LP, among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.